Post My Press Release

Free Press Release Distribution

Author: satishs (Page 1 of 25)

HbA1c Testing Devices Market Global Analysis, Trends, And Forecast 2018– 2026

HbA1c test is used to screen and diagnose for diabetes and prediabetes in patients. Hemoglobin molecule from the blood cell sticks to the glucose that gives rise to glycosylated hemoglobin molecule termed as hemoglobin A1C (HbA1C). Patients with high glucose level have more HbA1C present in blood. Average blood glucose level of a person can be diagnosed by measuring this glycosylated hemoglobin molecule. It is important for diabetic patient to know the glucose level, as there might be risk of diabetes related complications. HbA1c test is considered more effective than checking the blood glucose level. Blood glucose level gives the presence of glucose at a single point time whereas, the HbA1c test gives blood glucose level status for 2-3 months.

Increase in healthcare expenditure over diabetes management is owing to the growth of HbA1c testing devices market

Growing diabetes patient population globally is one of the important factor driving the growth HbA1c testing devices market. According to World Health Organization (WHO), the number of patients with diabetes has increased from 108 million in 1980 to 422 million in 2014. Around 5 million deaths were reported in 2015 due to diabetes and 2.2 million deaths were attributed to high blood glucose level. The data given by International Diabetes Federation showed the expenditure of 673 billion USD on diabetes in 2015. Additionally, rise prescription by physicians for HbA1c test is contributing to the growth of HbA1c testing devices market.

Request For Sample Copy of This Research Report: https://www.coherentmarketinsights.com/insight/request-sample/945

Wide use of bench top devices in diagnostic laboratories owing to domination of device segment

The global HbA1c testing devices market is segmented by device- type, by technology, by end users, and by region

On the basis of device- type, the HbA1c testing devices market is segmented into

Rising diabetic population is attributed to the growth of HbA1c testing devices market in Asia Pacific

Regional segmentation of HbA1c testing devices market by Coherent Market Insights comprises of North America, Latin America, Europe, Asia Pacific, Middle East, and Africa. The increase in number of patient population in North America is fuelling the growth of HbA1c testing devices market. Furthermore, the factors like established healthcare infrastructure and adoption to the technologically advanced medical devices, are helping North America to dominate in the HbA1c testing devices market. According to recent data given by International Diabetes Federation, there are around 109 million people in China and 69 million people in India with diabetes. The large number of diabetic population, unmet health needs, and development in healthcare sector are fuelling the growth of HbA1c testing devices market in Asia Pacific.

Product development is helping the organizations in HbA1c testing devices market to hold the top position

Key industry players operating the global HbA1c market includes Abbott Laboratories, Transasia Biomedicals limited, Alere Incorporated, Arkray Incorporated, Danaher Co., Bio-Rad Laboratories, Siemens Healthcare, F.Hoffmann-La Roche Limited, and Trinity Biotech Plc. The industry players are likely to get involved in product development for higher accuracy, reliable results, and quicker turnaround time for the analyzers. The factors like product development and approval of devices for diagnosis of diabetes are helping the organizations to hold the maximum share in the HbA1c testing devices market.

Click to read more on HbA1c Testing Devices Market

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Craniomaxillofacial Implants Market is Expected to Gain Popularity Across the Globe by 2026

Craniomaxillofacial implants is revolutionizing the healthcare industry by providing improved treatment options for facial and cranial injuries or any craniomaxillofacial abnormalities. 3D printing technology is also enabling manufacturers to provide customized implants according to the requirement of patients, which makes the market more attractive. Road accidents are considered to be the common reason for most of the craniomaxillofacial injuries. Increased incidence of facial fractures is expected to propel the global craniomaxillofacial market. According to a study examining the epidemiology of boxing injuries in the U.S., in 2013, head and neck injuries accounted for 22.5%, leading to increase in craniomaxillofacial surgeries. In 2012, a study conducted by the Michigan State University revealed that the rate of craniomaxillofacial injuries in people not wearing helmets was 37.2%. According to the Association for Safe International Road Travel in the U.S., almost 2.35 million people are injured each year in road accidents, which, in turn, support the craniomaxillofacial implants market.

Download the PDF brochure: https://www.coherentmarketinsights.com/insight/request-pdf/773

Market Dynamics

Craniomaxillofacial implants offer benefits such as customization based on the requirement of patient with the help of newly advanced 3D printing technology. Furthermore, growing prevalence of facial injuries is also expected to favor the growth of craniomaxillofacial implants. Emerging techniques for facial and cranial surgical procedures with higher success rate will also promote the use of craniomaxillofacial implants throughout the forecast period. Introduction of robotic arm assisted craniomaxillofacial surgery makes the surgery safer and efficient. Advancements in bioabsorable implants for cranial fixation are expected to drive the craniomaxillofacial implants market. Modern approaches such as image-based 3D modeling using computer-assisted design (CAD) and computer-assisted manufacturing (CAM) of implants to create surgical templates that are more precise than the other craniomaxillofacial implants, which is expected to increase the market for craniomaxillofacial implants.

Market Taxonomy

This report segments the global craniomaxillofacial implants for the medical sector market, on the basis of product, raw material, application, property, and region. On the basis of product, the global craniomaxillofacial implants market is classified into bone graft substitutes, distraction systems, total TMJ replacement systems, cranial flap fixation systems, thoracic fixation systems, dural repair products and screw, plates, and contourable mesh. Raw materials for craniomaxillofacial implants include metals, ceramics, polymers, and biomaterials. The internal fixators and external fixators are segmented under application segment. On the basis of property, the global craniomaxillofacial implants market is classified into resorbable fixators and non-resorbable fixators.

Key features of the study:

This report provides an in-depth analysis of global craniomaxillofacial implants in medical sector and provides market size (US$ Million) and Cumulative Annual Growth Rate (CAGR %) for the forecast period (2017 – 2025), considering 2016 as the base year

It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market

This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategy adopted by the leading players

It profiles leading players in the global craniomaxillofacial implants for medical sector market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments and strategies and future plans

Key companies covered as a part of this study include Stryker Corporation, Johnson & Johnson, Zimmer Biomet Holdings, Inc., Medtronic plc, Integra LifeSciences Holdings Corporation, OsteoMed L.P., Medartis AG, KLS Martin, Calavera Surgical Design, and Matrix Surgical USA.

Patient specific implants, 3D implants, growing demand for bioresorbable materials, and growing adoption of robot assisted surgeries have simplified the complexity of craniomaxillofacial surgeries. Whereas, advanced techniques, including computer-assisted craniofacial reconstruction, distraction osteogenesis, and endoscopic procedures, combined with refinements in surgical equipment such as resorbable plating and distractors, have improved surgical outcomes, while minimizing morbidity. The development of bone graft substitutes with the help of gene therapy and nanotechnology is also expected to drive the craniomaxillofacial implants market.

Some major players operating in the craniomaxillofacial implants market include Stryker Corporation, Johnson & Johnson, Zimmer Biomet Holdings, Inc., Medtronic plc, Integra LifeSciences Holdings Corporation, OsteoMed L.P., Medartis AG, KLS Martin, Calavera Surgical Design, and Matrix Surgicssal USA.

Click To Read More On Craniomaxillofacial Implants Market

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Leukemia Therapeutics Market 2026 by its Scientific Reviews and Key Side-Effects

Leukemia also known as blood cancer hinders ability of an individual to fight infection. It is characterized by formation of tumors in blood-forming tissues including bone marrow. Various type of leukemia include acute lymphoblastic leukemia, acute myeloid leukemia, and chronic lymphocytic leukemia. Fatigue, weight loss, frequent infections and easy bleeding or bruising are some of the symptoms of this disease. Treatment of early leukemia include monitoring and severe leukemia is treated with chemotherapy, followed by radiation and stem-cell transplant. According to Center for Disease Control and Prevention (CDC), in the U.S. around 45,360 people were diagnosed with leukemia in 2013, leading to 23,549 fatalities (13,625 men and 9,924 women). The condition is more prevalent among men than women.

Download The PDF Brochure: https://www.coherentmarketinsights.com/insight/request-pdf/528

Leukemia Therapeutics Market

On the basis of disease condition, the global leukemia therapeutics market is segmented into:

  • Acute lymphocytic leukemia
  • Chronic lymphocytic leukemia
  • Acute myeloid leukemia
  • Chronic myeloid leukemia

On the basis of treatment, the global leukemia therapeutics market is segmented into:

  • Immunotherapy
  • Targeted Therapy
  • Bone Marrow Transplant
  • Stem Cell Therapy

High diagnosis rate in developed economies supporting the leukemia therapeutics market growth in those regions

According to the Centre for Disease Control (CDC), around 14.1 million people were diagnosed with cancer in 2012, resulting in around 8.2 million fatalities. Around 19.3 million new cases of cancer are projected to be diagnosed by 2025. Leukemia cases are projected to be more in the developed economies such as North America and Europe, owing to genetic mutations caused by radiation exposure. There are about 54,270 new cases of leukemia in the U. S. annually. Leukemia makes up about 3% of all new cancer cases. According to the World Cancer Research Fund, one third of the cancer cases occur in economically developed economies such as US and Europe, owing to lack of physical activity, obesity, and/or poor nutrition. Furthermore, around 90% of the leukemia occur in the middle age and develop with the aging.

Furthermore, in emerging economies of Asia Pacific such as China and India, the leukemia therapeutics market is expected to grow at significant rate due high unmet medical needs. However, low diagnosis rate of leukemia and lack of proper healthcare facilities in few Asian and African countries is restraining growth of the leukemia therapeutics market in these regions.

Key players operating in the global leukemia therapeutics market include GSK, Eisai C., Pfizer, Biogen, Celgene, Novartis AG, Genzyme Corporation, Roche, and Bristol Myers Squibb Company (BMS). Major market players are focused on new product launch, product pipeline, merger & acquisitions, clinical trials and collaboration & agreements to maintain leading position in market. For instance, Novartis recently launched tyrosine kinase receptor FLT-3 for the treatment of leukemia. Pfizer implemented product expansion strategy to capture major market share, received Food and Drug Approval (FDA) for Bosulif drug.

Click To Read More Leukemia Therapeutics Market

About Us:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Breath Analyzer Market to See Incredible Growth By 2026

Breath analyzers are medical devices that are used to detect various compounds from exhaled breath of an individual. Breath analyzer mostly used to detect the blood alcohol content though it can also be used to detect the drugs, tuberculosis, asthma, and other diseases related to the respiratory system. However, it cannot measure the blood alcohol concentration directly, and further requires analysis of blood sample. The increasing road accidents due to over consumption of alcohol and the laws which have been enforced for prevention of this things are allowing the use of breath analyzers by law enforcement agencies or by person himself. Breath analyzers might be used in various areas such as by traffic policemen to detect over consumption of alcohol during driving, by professionals to restrict a drunken person to enter into the company premises or any other social places, or can be used in medical emergencies where many patients for emergency care are under the influence of alcohol that may give a diagnostic problem.

Request For Sample Copy of This Business Report: https://www.coherentmarketinsights.com/insight/request-sample/535

Stringent laws by government to avoid the rising cases of driving under the influence (DUI) of alcohol is owing to growth of breath analyzers market

Increase in cases of drunk and drive cases are giving rise to road accidents and to prevent this rising cases of accidents, government has enforced some mandatory laws. According to Center for Disease Control and Prevention (CDC) in 2014, 31% of deaths were due to alcohol impaired driving crashes in U.S. The stringent laws by government are helping to drive the breath analyzer market. Alcohol testing is important even at work places, where the increasing alcohol abuse allowing the use of breath analyzers to restrict such instances. The advancement in technology, portability of devices and its numerous uses are fuelling the growth of breath analyzer market. For instance, the advanced BreathKey- a product by OmegaPoint Systems, is the smallest analyzer in the world that is made with a keychain design so that it can be easy to carry anywhere by any individual. And the model g10 of the same company is the only keychain breath analyzer in the world with fuel cell alcohol censor.

Accuracy and mobility of fuel cell technology is helping this segment to hold the largest share in the breath analyzer market

The global breath analyzer market is segmented by applications, technology, by end users and by region.

On the basis of applications,

  • Alcohol detection
  • Drug base detection
  • Tuberculosis detection
  • Asthma detection
  • Pylori infection detection
  • Others

Technological advancements in the field of medical devices is major factor for domination of North America in breath analyzer market

Regional segmentation of global breath analyzers market by Coherent Market Insights comprises of North America, Latin America, Europe, Africa, Asia Pacific, and Middle East. North America dominates the breath analyzer market owing to the factors such as increasing road accidents, increase in number of infections and severe diseases, advancements in the medical devices, and well established healthcare infrastructure.

Low entry and exit barriers making the new players entry easier in the breath analyzer market

Key players operating the global breath analyzer market includes Akers Biosciences Inc., Dragerwerk AG & Co. KGaA, QUEST Products, Lifeloc Technologies, ENVITE- WISMER GmbH, AK GlobalTech corporation, Alcohol Countermeasure Systems Corporation, Intoximeter Inc., Alcovisor, and BACtrack Inc. The global breath analyzer market is highly fragmented and competitive due to various domestic players and some major international players.

Click to read more on Breath Analyzer Market

About Us:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Non-Hodgkins Lymphoma Treatment Market to See Incredible Growth By 2026

Non-Hodgkins Lymphoma (NHL) is a type of cancer that occurs due to abnormal functioning of B or T lymphocytes and leukocytes. Around 80% of the lymphomas arise in developing B cells and the remainder arise in developing T cells. This generally occurs in bone marrow, lymph nodes, spleen, blood and other organs that are part of lymphatic system. The patients suffering from non-Hodgkin’s lymphoma are observed with symptoms like fever, weight loss, swelling of lymph nodes, anorexia, fatigue and dyspnoea. Treatment of the NHL depends whether the cells are fast or slow growing and also whether it is spread in one area or different areas of the body. Treatment options for NHL include immunotherapy, chemotherapy, stem cell transplantation, targeted therapy, monoclonal antibody therapy and radiation therapy. If blood thickens in the patient due to presence of antibodies then plasmapheresis can also be carried out. Various products available for treating lymphoma include Deltasone, Adcertis, Folotyn, Adriamycin, Prednicot, Leukeran, Velcade, Thioplex and Decadron.

The launch of new drugs in the near future expected to support the growth of non-hodgkins lymphoma treatment market. For instance, a new drug Axicabtagene ciloleucel, received priority review status to get commercialize for the treatment of non-hodgkins lymphoma as a second line therapy. This drug is expected to launch in later of year 2017.

Request For Sample Copy This Research Report: https://www.coherentmarketinsights.com/insight/request-sample/547

Non-Hodgkins lymphoma treatment market taxonomy:

On the basis of type of non-hodgkins lymphoma, the non-hodgkins lymphoma treatment market is classified into:

  • B-cell lymphoma
  • T-cell lymphoma

Rituxan drug which is used to treat NHL and had been a front-line treatment regimen, though there has been an increasing rituximab resistance. To overcome this resistance, there has been various R&D practices that will create space in the market. For instance, Roche, Inc. is conducting phase IIIstudy of Gazyva/Gazyvaro in people with previously untreated with diffuse large B-cell lymphoma. . The extension of already marketed drugs such as Velcade as a front-line therapy for mantle cell lymphoma (MCL), Revlimid for maintenance therapy of diffuse large B-cell lymphoma (DLBCL) and Adcetris for CD30 T-cell lymphoma would be further contributing towards the non-hodgkins lymphoma treatment market growth. In 2016, the U.S. Government allocated US$ 5.2 billion to the National Cancer Institute (NCI) for cancer research and training purpose.

Increase in incidence of NHL will fuel the market

By geography, North America holds the major share in the market because of the high incidence rate of blood cancers in the U.S. According to Leukemia and Lymphoma Society, non-Hodgkin lymphoma is the seventh most common cancer in the U.S. and fifth in the UK. The National Cancer Institute estimated 72,580 new cases and 20,150 deaths in 2016 due to NHL in the U.S. According to the American Cancer Society, 20 cases of NHL, 6 cases of myeloma and 13 cases of leukemia were estimated per 100,000 population in 2014 in the U.S. Moreover, the organization states that, around 6 out of 10 people diagnosed with non-Hodgkin lymphoma are aged 65 and above. Also, NHL is much more common in men than in women.

Strategies implemented by competitors to drive the market:

Key players in the non-Hodgkin’s lymphoma treatment market inlcude Novartis International AG, Pharmacyclics, Inc., Bayer AG, F. Hoffmann LA Roche, Amgen, Inc., Eli Lilly and Company, Nordic Nanovector A/S and AbbVie, Inc. The prominent players are undertaking collaborative strategies for clinical research to yield new drugs which will aid them to gain competitive advantage. For instance, Novartis AG collaborated with Aduro Biotech in 2015 for clinical trial of novel immuno-oncology product such as ADU-S100 that is expected to treat non-Hodgkin’s lymphoma. Also, taking a step ahead, Roche launched a global network of immunotherapy centers named as Immunotherapy Centers of Research Excellence (imCORE) Network in 2016. This network intends to develop potential therapies for non-Hodgkin’s lymphoma by developing drugs that will simulate one’s immune system to fight the disease.

Click to read more on Non-Hodgkins Lymphoma Treatment Market

About Us:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Non-invasive Blood Pressure Monitors Market to Witness a Pronounce Growth by 2026

Blood pressure monitors are used to measure blood pressure of patients in hospitals, who are critically ill or are going to be operated of any surgical procedure. Blood pressure monitors are present in operating room, intensive care units, surgical recovery rooms, emergency departments and other critical care areas for frequent or continuous measurement of blood pressure. During critical conditions of patient, it is necessary to check blood pressure which plays an important role in diagnosis. Whereas, blood pressure measurement is integral to intensive care units to check vital signs and is also used to screen for hypertension, to estimate cardiovascular risk and manage, diagnose and treat acute and chronic medical conditions.

Furthermore, noninvasive blood pressure method is highly adopted, the most popular non-invasive techniques used are sphygmomanometer and auscultation. The non-invasive blood pressure monitor mostly used in intensive critical unit is sphygmomanometer.

Request For Sample Copy This Research Report: https://www.coherentmarketinsights.com/insight/request-sample/576

Non-invasive Blood Pressure Monitors Market Taxonomy

By Device Type

  • Automated BP Monitors
  • Ambulatory BP Monitors
  • Sphygmomanometers
  • BP Transducers

By Technology

  • Digital
  • Aneroid
  • Wearable

Rise in number of cardiovascular diseases expected to fuel the growth of non-invasive blood pressure monitors market

The risk of cardiovascular disease increase above 115/75 mmHg. In the UK, blood pressure is classified into 3 groups; low (90/60 or lower), normal (between 90/60 and 139/89), and high (140/90 or higher). Blood pressure fluctuates from minute to minute and show a circadian rhythm within 24 hours. In the U.S. leading cause of death are heart disease and stroke due to high blood pressure. According to Centers for Disease Control and Prevention, in year 2016, about 75 million adults of the U.S. had high blood pressure which is expected to support the growth of non-invasive blood pressure monitors market. Low blood pressure also favors the market of non-invasive blood pressure monitors as it is associated with serious symptoms such as, dizziness, nausea, fatigue, cold, pale skin or blurred vision.

Regional growth engines for the non-invasive blood pressure monitors market

On the basis of regional segmentation, the global colostomy bags market can be segmented into North America, Europe, Asia Pacific, Latin America, Middle East, and Africa. The emerging economics such as India, China, Brazil, and South Africa are expected to be major target geographies for market players. North America is expected to show growth in market due to its continuous growth in aging population and rate of disease related to high blood pressure. As according to Population Reference Bureau, the number of people of the U.S. aged over 65 years is projected to more than double from 46 million in 2016 to 98 million by 2060. Furthermore decline in price to make noninvasive blood pressure monitors cost effective for hospitals expected to favor the noninvasive blood pressure monitors market in Asia Pacific region.

Key players dominating in the non-invasive blood pressure monitors market

Non-invasive blood pressure monitor providers in the market are trying to offer broad and cost- effective range of non-invasive blood pressure monitors in the market by using advanced technology and innovation in products, which in turn is increasing competitive rivalry. In May 2017, Deltex Medical was granted patent for combined blood flow and blood pressure monitor by non-invasive method which will favor the growth of market. Other key players operating in the market are GE healthcare, SOMNOmedics, Eccosur SA, Koninklijke Philips N.V., Huntleigh Technology Ltd, Mortara Instrument, Schiller Americans Inc, American Diagnostic Corporation and Welch Allyn.

Click to read more on Non-invasive Blood Pressure Monitors Market

About Us:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Cushings Syndrome Market Clinical Review and Demands In Healthcare Industry 2018-2025

Cushing’s syndrome is a collection of symptoms and signs, which includes high blood pressure, reddish stretch marks, abdominal obesity, round red face, weak muscles, weak bones, a fat lump between the shoulders and fragile skin that heals slowly due to prolonged exposure to cortisol. Excessive cortisol-like medication such as prednisone or tumor that is produced due to excess cortisol by adrenal glands are the two basic factors that cause Cushing’s syndrome. Other tumors may also cause this disease, which are associated with inherited disorders such as multiple endocrine neoplasia type 1 and Carney complex. Most cases can be treated and cured by combination of surgery radiation or chemotherapy.

The key players dominating the global Cushing’s syndrome market

Increase in research and development in 2016, which includes development of clinical trials for RECORLEV for the treatment of endogenous Cushing’s syndrome by Strongbrigde Biopharma plc is expected to create competition and also favor the growth between various manufacture to lead the market. The key players operating in Cushing’s syndrome market include Corcept Therapeutics Inc., HRA Pharma, Strongbridge Biopharma plc. and Novartis AG.

Download the PDF brochure: https://www.coherentmarketinsights.com/insight/request-pdf/554

The most significant cause of Cushing’s syndrome is intake of glucocorticoids prescribed by a healthcare professional to cure other diseases such as asthma, rheumatoid arthritis or in immunosuppression after an organ transplant. Administration of synthetic ACTH can also lead to the condition. It may also occur in other animals such as cats, dogs, and horse. All the factors mentioned above are expected to favor the growth of Cushing’s syndrome market.

Cushing’s syndrome Market Taxonomy

By Drug Type

By End User

Rise in cortisol hormone fuels the growth of Cushing’s syndrome market

Hormonal disorder caused due to prolonged exposure of body’s tissue to high levels of hormone cortisol leads to Cushing’s syndrome, also called hypercortisolism. Adults aged in the age group of 20-50 years suffer from Cushing’s syndrome. It is rarely seen, though has risk of development in patient who are obese and also have type 2 diabetes, high blood pressure with poorly controlled blood glucose.

Regional growth engines that supports Cushing’s syndrome market

In terms of geography Cushing’s syndrome is segmented into North America, Europe, Asia-pacific, Middle East, Latin America and Africa. Due to presence of high income standard and health awareness in North America favors the growth of Cushing’s syndrome market.

Click To Read More On Cushings Syndrome Market

About Us:
Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Medical Disposables Market to Witness a Pronounce Growth by 2026

Medical disposables are products that are used in hospitals or in various medical fields for prevention of infections and for safety measures to meet the medical standards. The medical disposables are important to lower the risk of cross-contamination and infections that is a primary aim of healthcare professionals and governments globally. Medical disposables includes conventional syringes, disposable medical catheters, isolation gowns, procedure kits and trays, blood glucose tes

t strips, and wound care products. The medical disposables are the essential component of every hospital and they have one time usage and need to be disposed after use. Medical disposables are used in surgery, drug and fluid delivery, wound management, diagnostic testing, patient examination, incontinence management, sterilization, and to reduce the discomfort of patient. The need of safety and prevention from infections for the various medical fields such as surgical wear, hygiene, anesthesia and pediatric will expand the medical disposables market.

Request For Sample Copy of This Business Report: https://www.coherentmarketinsights.com/insight/request-sample/688

The rising demand in the preventive measures for hospital acquired infections and diseases driving the medical disposables market

Increase in incidence of hospital acquired infections and diseases and the increased focus on prevention from this infections is propelling the growth of medical disposables market. For instance, the data given by World Health Organization (WHO) shows that the prevalence of healthcare associated infection in 2010, in developed countries was 3.5% to 12% and it varies between 5.7% and 19.1% for low and middle income countries. Rising geriatric population, increase in incidence of incontinence problems, some mandatory guidelines that need be followed for safety of patients, and increasing demand for sophisticated healthcare facilities are some of the important factors that are driving the medical disposables market. Introduction of new value added, high quality safety products are the emerging trends in the medical disposables market.

Drug delivery disposables segment dominates in the medical disposables market due to the application of drug delivery products for sustained release drug therapies

The global medical disposables market is segmented by materials, by product type, by end user, and by region

On the basis of materials medical disposable market is segmented into

High healthcare spending drives the medical disposables market in North America

Regional segmentation of medical disposables market by Coherent Market Insights comprises North America, Latin America, Europe, Africa, Asia Pacific, and Middle East. Government initiatives, large patient pool, well established healthcare infrastructure, higher adoption rate of advanced technology, and growing awareness regarding infection control and cross-contamination in medical and healthcare fields are some major factors contributing to the domination of North America in the global medical disposables market. Asia Pacific is also a fast emerging market for medical disposables. Growing prevalence of chronic disorders due to sedentary lifestyle, presence of large number of players involved in the medical disposable product development, such as India and Japan, are expected to fuel the growth of medical disposables market.

Strong brand image and robust product portfolio positions international players as key participants in the medical disposables market

Key players operating the medical disposables market includes Abbott laboratories, Johnson & Johnson, Ansell Limited, Becton and Dickinson Company (BD), Boston Scientific Corporation, Medtronic Incorporated, Derma Sciences Incorporated, Kinetic Concepts, Medline Industries Inc., Cardinal Health Incorporated, and Minnesota Mining and Manufacturing Company (3M Company). International players such as 3M Company and Johnson & Johnson are dominating the medical disposables market.

Click to read more Medical Disposables Market

About Us:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Page 1 of 25

Powered by WordPress & Theme by Anders Norén